Kristie Gurley

Kristie Gurley is a Partner in Covington & Burling’s Washington, DC office, where she advises pharmaceutical companies on complex and evolving drug pricing and market access issues. Kristie’s advisory practice spans federal health care program coverage and reimbursement, Medicaid price reporting, agency engagement, payer contracting and formulary access, value-based contracting, and other issues under federal and state drug pricing regimes. 

In addition to regulatory counseling, Kristie advises on strategic commercial transactions, litigation opportunities, compliance and enforcement risk, and policy advocacy. Kristie previously served in the Office of the General Counsel of the U.S. Department of Health and Human Services. In this role, Kristie supported implementation of newly enacted programs under the Inflation Reduction Act, including as a lead attorney for the first cycle of the Medicare Drug Price Negotiation Program, as well as other Medicare and Medicaid initiatives such as the development of innovative drug pricing models.